Global Bio-chem Technology Group Company Limited
GBCMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $2 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $5 | $8 | $8 |
| Enterprise Value | $4 | $7 | $10 | $10 |
| Revenue | $2 | $1 | $0 | $1 |
| % Growth | 45.6% | 10,709% | -98.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 10.9% | 3.2% | 62.1% | 6.5% |
| EBITDA | $0 | -$0 | -$0 | $1 |
| % Margin | 0.8% | -3.2% | -3,690.2% | 105.2% |
| Net Income | $1 | $4 | -$1 | -$0 |
| % Margin | 38.5% | 307.5% | -11,352.9% | -53.7% |
| EPS Diluted | 4.3 | 23.5 | -8 | -2.25 |
| % Growth | -81.7% | 393.8% | -255.6% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$1 |